Iron-(Fe3+)-Dependent Reactivation of Telomerase Drives Colorectal Cancers

Page view(s)
20
Checked on Mar 08, 2025
Iron-(Fe3+)-Dependent Reactivation of Telomerase Drives Colorectal Cancers
Title:
Iron-(Fe3+)-Dependent Reactivation of Telomerase Drives Colorectal Cancers
Journal Title:
Cancer Discovery
Keywords:
Publication Date:
17 June 2024
Citation:
Shanmugam, R., Majee, P., Shi, W., Ozturk, M. B., Vaiyapuri, T. S., Idzham, K., Raju, A., Shin, S. H., Fidan, K., Low, J.-L., Chua, J. Y. H., Kong, Y. C., Qi, O. Y., Tan, E., Chok, A. Y., Seow-En, I., Wee, I., Macalinao, D. C., Chong, D. Q., … Tergaonkar, V. (2024). Iron-(Fe3+)-Dependent Reactivation of Telomerase Drives Colorectal Cancers. Cancer Discovery, OF1–OF24. https://doi.org/10.1158/2159-8290.cd-23-1379
Abstract:
Abstract Over-consumption of iron-rich red meat and hereditary or genetic iron overload are associated with an increased risk of colorectal carcinogenesis, yet the mechanistic basis of how metal-mediated signaling leads to oncogenesis remains enigmatic. Using fresh colorectal cancer samples we identify Pirin, an iron sensor, that overcomes a rate-limiting step in oncogenesis, by reactivating the dormant human telomerase reverse transcriptase (hTERT) subunit of the telomerase holoenzyme in an iron-(Fe3+)-dependent manner and thereby drives colorectal cancers. Chemical genetic screens combined with isothermal dose-response fingerprinting and mass spectrometry identified a small molecule SP2509 that specifically inhibits Pirin-mediated hTERT reactivation in colorectal cancers by competing with iron-(Fe3+) binding. Our findings, first to document how metal ions reactivate telomerase, provide a molecular mechanism for the well-known association between red meat and increased incidence of colorectal cancers. Small molecules like SP2509 represent a novel modality to target telomerase that acts as a driver of 90% of human cancers and is yet to be targeted in clinic. Significance: We show how iron-(Fe3+) in collusion with genetic factors reactivates telomerase, providing a molecular mechanism for the association between iron overload and increased incidence of colorectal cancers. Although no enzymatic inhibitors of telomerase have entered the clinic, we identify SP2509, a small molecule that targets telomerase reactivation and function in colorectal cancers.
License type:
Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
Funding Info:
This research / project is supported by the Agency for Science, Technology and Research (A*STAR) - Central Research Fund
Grant Reference no. :

This research / project is supported by the National Research Foundation (NRF) - Competitive Research Programme
Grant Reference no. : NRF-CRP26-2021-0001

This research / project is supported by the National Medical Research Council (NMRC) - Open Fund - Individual Research Grant
Grant Reference no. : OFIRG21jun-0101

This research / project is supported by the National Medical Research Council - NA
Grant Reference no. : MOH-CSAINV17nov-0003

This research / project is supported by the National Medical Research Council - NA
Grant Reference no. : MOH-000634-00
Description:
ISSN:
2159-8274
2159-8290
Files uploaded:

File Size Format Action
cd-23-1379.pdf 13.07 MB PDF Open